Tulsi Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.50 Cr
as on 16-11-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.26 Cr
as on 16-11-2024
- Revenue -4.06%
(FY 2023)
- Profit -57.82%
(FY 2023)
- Ebitda -36.47%
(FY 2023)
- Net Worth 14.81%
(FY 2023)
- Total Assets 49.06%
(FY 2023)
About Tulsi Biosciences
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹16.26 Cr.
Sharadchandra Thakar and Kunal Thakar serve as directors at the Company.
- CIN/LLPIN
U24230GJ2009PTC057124
- Company No.
057124
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Tulsi Biosciences Private Limited offer?
Tulsi Biosciences Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Wash, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Emulsion Paints, Styrene Acrylic Emulsion, Shampoo Base, Hand Wash Concentrate, Soap Raw Material, Natural Soap Base.
Who are the key members and board of directors at Tulsi Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharadchandra Thakar  | Director | 01-Jun-2009 | Current |
| Kunal Thakar | Director | 01-Jun-2009 | Current |
Financial Performance and Corporate Structure Insights of Tulsi Biosciences.
Tulsi Biosciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.06% decrease. The company also saw a substantial fall in profitability, with a 57.82% decrease in profit. The company's net worth Soared by an impressive increase of 14.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tulsi Biosciences?
In 2023, Tulsi Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jan 2020 | ₹2.58 M | Open |
Hdfc Bank Limited Creation Date: 08 Jul 2019 | ₹0.50 M | Open |
Hdfc Bank Limited Creation Date: 18 Apr 2019 | ₹1.80 M | Open |
How Many Employees Work at Tulsi Biosciences?
Tulsi Biosciences has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tulsi Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tulsi Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
